Phase 2 study of amrubicin in previously treated patients with malignant pleural mesothelioma.

Trial Profile

Phase 2 study of amrubicin in previously treated patients with malignant pleural mesothelioma.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Sep 2011

At a glance

  • Drugs Amrubicin (Primary)
  • Indications Mesothelioma
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Sep 2011 Status of the trial is recruiting as reported by University Hospital Medical Information Network - Japan record..
    • 28 Sep 2011 Planned initiation date is Sep 2011 as reported by University Hospital Medical Information Network - Japan record.
    • 22 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top